EGFR and cancer: A growing body of evidence now demonstrates that asporin acts as an extracellular matrix component or intracellular protein that positively or negatively controls proliferation, invasion, and metastasis of cancer cells by regulating the TGF-β, EGFR, and CD44 signaling pathways (10).